As illustrated in Figure S2, GDF6 protein expression varies markedly across cancer types; melanoma exhibits the highest expression (~90% positive staining), followed by thyroid cancer with moderate expression (~50%), while prostate cancer and carcinoid show lower expression levels (~20–30%). Here, GDF6 is linked to prostate carcinoma.